In the complex landscape of U.S. healthcare, a disturbing trend has emerged: insurance companies increasingly prioritize cost-saving measures over patient care, often with devastating consequences.
This systemic issue is starkly illustrated by the following chilling anecdote.
My Story
Years ago, I lost my daughter during delivery, which was tragic enough, but what my then-girlfriend and I had to endure with our insurance company was unconscionable.
They refused to pay for an emergency c-section and related costs, claiming we didn't preplan that surgical procedure at least 90 days ahead of time—perhaps even six months, though I can't recall the exact standard from 2006.
We faced a six-figure hospital bill, thanks to our insurance carrier.
After several phone calls, the hospital finally agreed to lower the bill, but only after my girlfriend broke down sobbing hysterically on the phone, pleading, “You want me to pay all this money for a baby I lost—for my dead baby?”
This heart-wrenching account encapsulates the cold, calculated approach that many insurance companies employ when deciding whether to approve or deny claims.
It's not just about policy terms or medical necessity; it's about the stark reality that in the eyes of these corporations, a human life can be reduced to a simple cost-benefit analysis.
The U.S. health insurance system has long been under scrutiny for practices that seem to value profits over patient well-being.
However, as we delve deeper into the industry's practices, we uncover a systemic problem that goes beyond isolated incidents.
This analysis explores how insurance companies' cost-benefit analyses affect treatment approvals, often leading to denials of necessary medical care, and examines the broader implications of these practices on public health and individual lives.
The Scale of the Problem
The scope of claim denials and the prioritization of profits over patients illustrate the depth and breadth of this troubling issue.
High Denial Rates
UnitedHealthcare (UHC), the largest private health insurer in the U.S., has been reported to deny approximately 32% of submitted claims, almost double the industry average. This high denial rate is not unique to UHC but reflects a broader industry trend.
For comparison:
Anthem has a denial rate of 23%
Aetna and CareSource both have rates of 20%
These figures are significantly higher than the 5-10% range considered normal in the healthcare industry, with rates above 10% entering a "red zone" for financial stability in healthcare centers.
However, these denial rates are not random; they are rooted in a calculated financial strategy.
Insurance companies assess the value of your life based on how much money they can extract in premiums over your lifetime versus how much they might have to pay out in claims.
If the cost of your care outweighs their projected profits, your treatment may be denied—regardless of the medical necessity or the impact on your life.
This cold, profit-driven calculation explains why so many patients are left without the care they need: in the eyes of insurers, your life simply isn’t worth enough.
Impact on Patients
Beyond the numbers, the consequences of these denials have real-world implications that directly affect people’s health and well-being.
The high rate of claim denials has profound impacts on patients:
Health Risks: Nearly one in four physicians reported that prior authorization led to a serious adverse event for a patient in their care.
Financial Burden: Patients often face unexpected medical bills due to denied claims, leading to financial strain and sometimes the inability to afford necessary treatments.
Delayed or Foregone Care: Patients whose claims are denied may delay or skip follow-up care due to financial constraints, potentially worsening their health conditions.
Cost-Benefit Analysis in Insurance Practices
Insurance companies’ decision-making processes reveal how systemic financial pressures can drive patient care decisions.
Profit Margins and Financial Pressures
The health insurance industry operates on relatively low-profit margins, typically between 2% to 3%, with recent data showing a net profit margin of 4.99% for accident and health insurance companies.
This financial pressure drives insurers to implement aggressive cost-saving strategies.
Cost-Saving Strategies
While marketed as efficiency measures, these strategies often come at the expense of patients’ health and access to care.
Use of AI and Algorithms: Insurers, including UHC, have been reported to use AI-powered tools to deny claims automatically.
This practice has been particularly noted in Medicare Advantage plans, where denial rates for post-acute care rose significantly from 10.9% in 2020 to 22.7% in 2022.Medical Management Techniques: Insurers use utilization management and fraud prevention methods to control costs.
While these can be legitimate tools, they are often criticized for prioritizing cost savings over patient care.Data Analytics: Leading insurers leverage data analytics to improve decision-making and operational efficiency, including using machine learning for predictive analytics and improving claims processing.
Real Stories of Denial
Examples involving actual patients highlight the devastating human cost of these calculated decisions.
UnitedHealthcare and the McNaughton Case
Christopher McNaughton, a student with severe ulcerative colitis, faced denial of coverage for a costly but effective treatment regimen.
UHC deemed it "not medically necessary" despite its success in managing his condition, attempting to push for cheaper alternatives that had previously failed.
AI-Driven Denials
UHC and Humana have faced lawsuits for allegedly using an AI tool, nHPredict, to deny coverage for medically necessary treatments, overriding physicians' determinations.
EviCore and "Denials for Dollars"
EviCore, a company providing prior authorization services for major insurers, has been accused of using algorithms to increase denial rates, allegedly adjusting its algorithm to send more requests for review and increase the likelihood of denials.
Ethical and Legal Implications
The ethical and legal dimensions of these practices reveal the systemic flaws in the healthcare industry.
Ethical Concerns
The practices of insurance companies raise significant ethical concerns:
Prioritizing Profits Over Patient Care: Using cost-benefit analyses that weigh a patient's life expectancy against treatment costs fundamentally undermines the principle of providing necessary medical care.
Lack of Transparency: There is a significant lack of transparency in how often insurers deny claims and the criteria used for these decisions.
Discrimination and Bias: Using algorithms and AI in decision-making processes raises questions about potential biases, particularly those affecting vulnerable populations.
Legal Challenges
Insurance companies’ actions have not gone unnoticed, with legal challenges mounting against these practices.
Lawsuits Against AI Use: UHC and other insurers face legal action for using AI tools to deny claims, particularly in Medicare Advantage plans.
Regulatory Scrutiny: The Department of Health and Human Services (HHS) is tasked with monitoring denials, but enforcement has been limited, and comprehensive data collection has not been achieved.
State-Level Actions: Some states have implemented risk corridors where profits and losses are shared between states and health plans to provide financial stability.
Impact on Public Health
The systemic issues in the insurance industry extend far beyond individual cases, impacting the nation's health as a whole.
Exacerbation of Health Disparities
At-risk populations face higher rates of claim denials for preventive care, exacerbating inequitable access to healthcare.
Increased Healthcare Costs
When patients delay or forgo care due to denials, it can lead to increased healthcare costs in the long run as untreated conditions become more severe.
Public Health Challenges
Lack of timely care can contribute to the spread of infectious diseases and other public health challenges.
Conclusion
The evidence strongly supports the notion that insurance companies' cost-benefit analyses often result in the denial of necessary treatments, prioritizing financial considerations over patient health.
This practice affects individual patients and has broader implications for public health and healthcare equity.
The high denial rates, use of AI in automated denials, and numerous legal challenges paint a picture of an industry where a patient's life and health are often deemed not valuable enough to justify the cost of treatment.
This systemic issue calls for significant reforms in the health insurance industry, including increased transparency, stronger regulatory oversight, and a reevaluation of treatment decisions.
Call to Action
Your life, and the lives of countless others, are worth more than the profits of any corporation.
If you’ve ever experienced the devastating consequences of a denied insurance claim or witnessed someone suffer due to profit-driven healthcare practices, now is the time to make your voice heard.
Here’s how you can take action:
Share your story: Post your experience on social media to raise awareness of the real consequences of these practices. Use hashtags like #ProfitOverPatients or #HealthcareReform to join the conversation.
Demand accountability: Reach out to your legislators and demand stronger oversight of insurance companies and their practices. Advocate for transparency and regulations that prioritize patient care over corporate profits.
Amplify this message: Share articles like this one to spark discussions with your friends, family, and community. Together, we can push for a healthcare system that values people over profits.
Your voice matters.
By speaking out, you can help expose these injustices and demand change. Let’s work together to ensure that no one’s life is ever reduced to a cost-benefit analysis again.
Stay informed and inspired—join my Substack community today!
Paid subscribers receive weekly eBooks that dive deeper into select topics.